title: Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM data.
authors.affiliation: Hématologie Clinique, Hôpital de Brabois, 54511 Vandoeuvre, France.
authors.forename: F
authors.initials: F
authors.lastname: Witz
authors.forename: J L
authors.initials: JL
authors.lastname: Harousseau
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: J Y
authors.initials: JY
authors.lastname: Cahn
authors.forename: B
authors.initials: B
authors.lastname: Witz
authors.forename: C
authors.initials: C
authors.lastname: Loos
authors.forename: M P
authors.initials: MP
authors.lastname: Chevalier
authors.forename: O
authors.initials: O
authors.lastname: Guibon
authors.forename: P
authors.initials: P
authors.lastname: Berthaud
authors.forename: B
authors.initials: B
authors.lastname: Lioure
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D000964:Antimetabolites, Antineoplastic; D011994:Recombinant Proteins; D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor